SYBX Synlogic, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Synlogic (SYBX) Stock: Buy, Sell, or Hold?

$0.56
-0.56 (-50.00%) β–Ό
5d: -50.44% 30d: -49.09% 90d: -67.06%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
42/100
Position
FAIR
Wall Street Target
$1.00
+78.6% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.56 / $1.27
Trend: Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: SYBX is down 50.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When SYBX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: SYBX is currently trading at $0.56, which is considered fair based on recent price action.

Technical Outlook: Technically, SYBX is in a downtrend. The price is currently testing key support at $0.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 50.0% recently.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+78.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 42/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 64.2%

Trading Range & Key Levels

Support Level $0.56
Resistance Level $1.27
Current Trend Downtrend
Technical data as of Jan 20, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BEARISH: Downward momentum (-50.0%)
  • BULLISH: Trading 78.6% below Wall St target ($1.00)
  • WARNING: Composite score 42/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Wall Street Target $1.00 (+78.6%)
Revenue Growth (YoY) -100.0%
Share SYBX Analysis

Share this live SYBX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 13, 2026 5:53 AM ET
Data refreshes hourly during market hours. Next update: 6:53 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SYBX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
25 analysts
$261 38 SELL
IONS
Ionis Pharmaceuticals Inc
STRONG BUY
25 analysts
$84 45 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 41 HOLD
ABVX
Abivax SA American Depos…
STRONG BUY
12 analysts
$164 64 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive SYBX Research Pages
SYBX Technical Chart SYBX Price Prediction SYBX Intrinsic Value DCF SYBX Earnings Date SYBX Investment Advisor SYBX Fair Price Analyzer SYBX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals